Effectiveness of Core-Needle US Guided Biopsy as Primary Tool For Diagnosis of Thyroid Nodules

The study aimed to determine the best intervention between Core biopsy and Fine needle aspiration in diagnosis of thyroid malignancy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Thyroid Nodule Endocrine Gland Neoplasms Endocrine System Diseases Head and Neck Neoplasms Neoplasms Neoplasms by Site Thyroid Diseases Thyroid Gland; Node Thyroid Neoplasms

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients with nodules larger than 1 cm in diameter and suspicious ultrasound criteria with TIRADS category III or higher.

Exclusion criteria

Patients with a history of hemodynamic instability or inadequate coagulation profile were excluded

Treatment and study plan

FNB

Procedure

Fine needle aspiration from the nodules

Core Biopsy

Procedure

Core biopsy from thyroid nodules

Primary outcomes

Number of samples in FNB and CNB matching the final pathology

Time frame: 7 days

Comparing number of samples in FNB and CNB that make same diagnosis as the final postoperative pathology

Sponsors and collaborators

Lead sponsor

Kafrelsheikh University

Other

Collaborators

Alexandria University

Registry information

Official study title

Effectiveness of Core-Needle US Guided Biopsy as Primary Tool For Diagnosis of Thyroid Nodules, A Prospective Study

Important dates

Study start: 2017
Primary completion: 2018
Study completion: 2018
First posted: Feb 17, 2021
Registry last updated: Feb 17, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed